StonvexLoading…
StonvexStonvexStonvexCore line items from MTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.07B | $2.12B | $2.17B | $2.13B |
Operating Income | $47.40M | $286.50M | $171.80M | $214.80M |
Net Income | $-18.40M | $167.10M | $84.10M | $122.20M |
EPS (Diluted) | $-0.59 | $5.17 | $2.58 | $3.73 |
Total Assets | $3.47B | $3.39B | $3.35B | $3.40B |
Total Liabilities | $1.72B | $1.61B | $1.66B | $1.79B |
Cash & Equivalents | $329.00M | $333.10M | $317.20M | $247.20M |
Free Cash Flow OCF − CapEx | $86.60M | $146.90M | $140.10M | $23.40M |
Shares Outstanding | 31.03M | 31.90M | 32.40M | 32.50M |